AzTrials
AzTrials

Research institution

St. Jude Children's Research Hospital Clinical Trials

Studies where St. Jude Children's Research Hospital is the lead sponsor: what is enrolling now, by phase, condition and country.

439 registered studies

In numbers

Open to volunteers
100
Active
154
With results posted
78
All registered
439

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 100
  • Hemophilia A, Hemophilia B

    Liver Biopsy Following Gene Therapy For Hemophilia

    • Not yet recruiting
    • Age: 18 to 80 years
    • Observational study
    • Surgery or procedure

    This observational study will obtain liver biopsy samples and evaluate the long-term effect of adeno-associated virus (AAV)-mediated gene therapy on the liver tissue in adult patients with hemophilia A or hemophilia B who have…

    Trial name
    NCT05932914
    Testing
    Liver Biopsy
    Where
    United States
    Volunteers
    8 people
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT05932914
  • Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia

    Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

    • Recruiting
    • Age: 1 year to 30 years
    • Phase 1
    • Pill or oral medicine
    • Injection or infusion

    This is a research study to find out if adding a new study drug called revumenib to commonly used chemotherapy drugs is safe and if they have beneficial effects in treating patients with acute myeloid leukemia (AML) or acute…

    Conditions
    Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Acute Leukemia of Ambiguous Lineage
    Trial name
    NCT06177067
    Testing
    Revumenib, Venetoclax, Azacitidine
    Where
    10 sites in United States
    Volunteers
    24 people
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT06177067
  • Drug Toxicity

    Real World Asparaginase Therapy Toxicity

    • Not yet recruiting
    • Age: All ages
    • Observational study

    This research study is being done to learn more about the short term and long term side effects of treatment with asparaginase drugs, which are commonly used in acute lymphoblastic leukemia (ALL) or acute lymphoblastic lymphoma…

    Trial name
    NCT07008027
    Where
    United States
    Volunteers
    200 people
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT07008027
  • Healthy Volunteer

    Positron Emission Tomography (PET) Imaging of Reactive Oxygen and Nitrogen Species: Human Observation of Retention and Safety of [18F]-Fluoroedaravone

    • Not yet recruiting
    • Age: 18 to 75 years
    • Early Phase 1
    • Injection or infusion
    • Surgery or procedure

    This first-in-human research study will test the safety of a new PET imaging tracer called[18F]fluoroedaravone ([18F]FEDV) in healthy adults.

    Trial name
    NCT07801976
    Testing
    [18F]Fluoroedaravone ([18F]FEDV), PET/CT Imaging
    Volunteers
    10 people, healthy volunteers welcome
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT07801976
  • Spinal Muscular Atrophy

    A Registry of Cases of Spinal Muscular Atrophy

    • Recruiting
    • Age: All ages
    • Observational study

    Because no long-term record of prenatal Spinal Muscular Atrophy (SMA) treatment exists, this study will address an important gap in the understanding of the safety and benefit of treatment while in the womb.

    Trial name
    NCT07805278
    Where
    United States
    Volunteers
    30 people
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT07805278
  • Stigma

    Stigma Healing Inventory Evaluation

    • Not yet recruiting
    • Age: 8 years and older

    Investigators want to learn more about the way stigma affects children with cancer and their caregivers. They hope to develop an intervention to lessen stigma for children with cancer and their caregivers in settings around the…

    Trial name
    NCT07882927
    Testing
    Pediatric Stigma Education, Pediatric Stigma Standard Education and Adapted Stigma Intervention
    Where
    United States
    Volunteers
    2,980 people
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT07882927
  • Survivors of Childhood Cancer, Acute Lymphoblastic Leukemia, Childhood

    Feasibility and Acceptability of Remote Saliva Collection

    • Recruiting
    • Age: 8 to 18 years
    • Observational study
    • Lifestyle or therapy programme

    The purpose of this study is to evaluate the practicality and acceptability of collecting biological samples and health information from childhood survivors of acute lymphoblastic leukemia (ALL) and their siblings.

    Trial name
    NCT07884474
    Testing
    Salivary Cortisol Collection, Blood Biomarker Collection, Hair Cortisol Collection
    Where
    United States
    Volunteers
    100 people, healthy volunteers welcome
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT07884474
  • Sickle Cell Disease

    Gene Editing For Sickle Cell Disease

    • Recruiting
    • Age: 18 to 24 years
    • Phase 1
    • Injection or infusion

    This study is being done to test the safety of a new treatment called gene editing in Sickle Cell Disease (SCD) patients and to see if a single dose of this genetically modified cellular product will increase the amount of a…

    Trial name
    NCT06506461
    Testing
    Plerixafor, Busulfan, Gene-modified CD34+ cells
    Where
    United States
    Volunteers
    25 people
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT06506461
  • Bone Marrow Failure Syndrome

    Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders

    • Recruiting
    • Age: 18 to 25 years
    • Phase 1
    • Injection or infusion
    • Surgery or procedure

    The purpose of this study is to investigate mobilization and collection of HSPCs in patients with bone marrow failure syndromes (BMFS) using granulocyte-colony stimulating factor (otherwise known as Filgrastim) with plerixafor to…

    Trial name
    NCT07585136
    Testing
    Filgrastim, Plerixafor, Leukapheresis
    Where
    United States
    Volunteers
    12 people
    Sponsor
    St. Jude Children's Research Hospital
  • Atherosclerotic Cardiovascular Disease

    Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE

    • Recruiting
    • Age: 18 years and older
    • Observational study

    Childhood cancer survivors are at increased risk for premature atherosclerotic cardiovascular disease (ASCVD) due to cancer treatment-related exposures, including radiation therapy and platinum-based chemotherapy.

    Trial name
    NCT07594392
    Testing
    Coronary Artery Calcium Scan, Carotid Artery Ultrasound, Lipoprotein(a) Measurement
    Where
    United States
    Volunteers
    650 people
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT07594392

Completed, with results posted

All –
  • Acute Lymphoblastic Leukemia

    Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)

    • Completed
    • Age: 18 to 39 years
    • Medical device
    • Results posted

    Long-term survivors of ALL are at-risk for neurocognitive impairment, particularly in the area of executive functioning. Relatively limited research has focused on interventions for improving neurocognitive outcomes in long-term…

    Trial name
    NCT04007601
    Testing
    Active tDCS
    Where
    United States
    Volunteers
    127 people
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT04007601
  • Neuroblastoma

    Therapy for Children With Advanced Stage Neuroblastoma

    • Completed
    • Age: Up to 18 years
    • Phase 2
    • Pill or oral medicine
    • Injection or infusion
    • Results posted

    Neuroblastoma is the most common extracranial solid tumor in childhood, with nearly 50% of patients presenting with widespread metastatic disease.

    Trial name
    NCT01857934
    Testing
    cyclophosphamide, topotecan, hu14.18K322A
    Where
    United States
    Volunteers
    153 people
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT01857934
  • Desmoplastic Small Round Cell Tumor, Ewing Sarcoma of Bone or Soft Tissue

    Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

    • Completed
    • Age: Up to 25 years
    • Phase 2
    • Injection or infusion
    • Surgery or procedure
    • Results posted

    This protocol will study treatment for Ewing sarcoma family of tumors (ESFT) and desmoplastic small round cell tumor (DSRCT). Participants with ESFT will be divided into two treatment groups, A or B, based on tumor…

    Conditions
    Desmoplastic Small Round Cell Tumor, Ewing Sarcoma of Bone or Soft Tissue, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
    Trial name
    NCT01946529
    Testing
    vincristine, doxorubicin, cyclophosphamide
    Where
    United States
    Volunteers
    24 people
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT01946529
  • Osteosarcoma

    A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

    • Completed
    • Age: 12 to 49 years
    • Phase 2
    • Injection or infusion
    • Results posted

    This clinical trial seeks to determine if avelumab will be effective in facilitating removal of all gross tumor in the event of a relapse of osteosarcoma in pediatric patients.

    Trial name
    NCT03006848
    Testing
    Avelumab, Questionnaires
    Where
    4 sites in United States
    Volunteers
    19 people
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT03006848
  • Hypertension, Osteonecrosis

    Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma

    • Completed
    • Age: 10 years and older
    • Phase 2
    • Results posted

    This is a randomized unblinded Phase II clinical trial evaluating the impact of intensive antihypertensive control (targeted to the 50-75th percentile for age, sex, and height) compared to conventional antihypertensive control…

    Conditions
    Hypertension, Osteonecrosis, Osteonecrosis Due to Drug
    Trial name
    NCT04401267
    Testing
    Intensive Antihypertensive Therapy, Conventional Antihypertensive Therapy, Symptom Survey
    Where
    2 sites in United States
    Volunteers
    51 people
    Sponsor
    St. Jude Children's Research Hospital
    Can I take part? NCT04401267

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in